Health apps now more popular than ever in the UK
pharmafile | October 16, 2015 | News story | Medical Communications | apps, digital pharma, health technology, technology
The use of health apps has considerably increased over the past years, according to a new survey that has found that more than half of adults in the UK now use technology to manage their health.
Research published in the UK Digital Health Report by PushDoctor.co.uk found that checking medical symptoms, monitoring exercise levels, establishing individual BMI scores, monitoring heart rates and checking blood pressure are the top five most common ways people are now using technology to understand and manage wellbeing.
Figures indicate that 71% of British adults feel positive about using technology to better understand their bodies, their habits and how they can directly affect state of health. Their belief is that technology is helping them to be more aware of and more in control of their health, the survey found.
The data shows that at least 1 in 2 of all age groups – except for over 65s – have used a gadget to monitor their health, with 18-24 year olds leading the way at 91%. However, even more than 1 in 3 (37%) of over 65 year olds have monitored their wellbeing using technology.
Eren Ozagir, chief executive of PushDoctor.co.uk, says: “We use technology to manage nearly every aspect of our lives – from socialising, to organising our finances and heating of our homes. The adoption of health-tech by the general population remains a natural next step; with more and more people discovering how their health information can be used to guide and control and enhance their everyday lives.”
Top five uses of health technology:
- Checking medical symptoms
- Monitoring exercise levels
- Calculating BMI scores
- Monitoring heart rates
- Checking blood pressure
Yasmita Kumar
Related Content
Expansion for first FDA-approved video game for ADHD treatment
Akili Interactive has announced the expansion of its prescription video game treatment, EndeavorRx, with the …
Next generation organ-on-a-chip technology adopted by King’s College London
CN Bio, an organ-on-a-chip company that designs and manufactures single and multi-organ microphysiological systems (MPS), …
LegoChem and Iksuda expand License Agreement for antibody drug conjugates
Iksuda Therapeutics, a developer of antibody drug conjugates (ADCs), has announced the expansion of the …
